X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (76) 76
humans (64) 64
hematology (49) 49
female (43) 43
male (42) 42
middle aged (40) 40
oncology (38) 38
aged (30) 30
adult (28) 28
treatment outcome (21) 21
prognosis (20) 20
myelodysplastic syndromes (19) 19
animals (18) 18
cancer (18) 18
leukemia, myeloid, acute - genetics (18) 18
transplantation (17) 17
young adult (17) 17
aged, 80 and over (16) 16
leukemia (16) 16
adolescent (15) 15
leukemia, myeloid, acute - mortality (15) 15
prospective studies (15) 15
analysis (14) 14
leukemia, myeloid, acute - drug therapy (14) 14
stem cells (14) 14
acute myeloid-leukemia (13) 13
mds (13) 13
stem-cell transplantation (13) 13
germany (12) 12
mice (12) 12
mutation (12) 12
hemic and lymphatic diseases (11) 11
abridged index medicus (10) 10
aml (10) 10
hematopoietic stem cells (10) 10
myelodysplastic syndromes - drug therapy (10) 10
myelodysplastic syndromes - genetics (10) 10
risk factors (10) 10
bone-marrow (9) 9
cell biology (9) 9
diagnosis (9) 9
medicine, research & experimental (9) 9
azacitidine (8) 8
chemotherapy (8) 8
fms-like tyrosine kinase 3 - genetics (8) 8
mutations (8) 8
progenitor cells (8) 8
survival (8) 8
survival rate (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
cell line, tumor (7) 7
cells, cultured (7) 7
cytogenetics (7) 7
gene expression (7) 7
kaplan-meier estimate (7) 7
leukemia, myeloid, acute - therapy (7) 7
medicine & public health (7) 7
myelodysplastic syndrome (7) 7
patients (7) 7
recommendations (7) 7
risk (7) 7
scoring system (7) 7
stem cell transplantation (7) 7
therapy (7) 7
time factors (7) 7
transplantation, homologous (7) 7
acute myeloid leukemia (6) 6
adults (6) 6
bone marrow (6) 6
care and treatment (6) 6
classification (6) 6
comorbidity (6) 6
disease-free survival (6) 6
follow-up studies (6) 6
hematology, oncology and palliative medicine (6) 6
hematopoietic stem cell transplantation (6) 6
hematopoietic stem cell transplantation - methods (6) 6
lenalidomide (6) 6
leukemia, myeloid, acute - diagnosis (6) 6
medical research (6) 6
research (6) 6
risk assessment (6) 6
stem-cells (6) 6
trial (6) 6
azacitidine - administration & dosage (5) 5
chromosome aberrations (5) 5
decitabine (5) 5
drug administration schedule (5) 5
flow cytometry (5) 5
fms-like tyrosine kinase 3 - metabolism (5) 5
hematopoietic stem cells - drug effects (5) 5
internal tandem duplication (5) 5
medicine, experimental (5) 5
myelodysplastic syndromes - mortality (5) 5
nuclear proteins - genetics (5) 5
prognostic-significance (5) 5
proteins (5) 5
rats (5) 5
regeneration (5) 5
research paper (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EMBO Molecular Medicine, ISSN 1757-4676, 04/2015, Volume 7, Issue 4, pp. 477 - 487
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1338 - 1347
Journal Article
Science, ISSN 0036-8075, 12/2017, Volume 358, Issue 6367, p. eaan4368
Kinase inhibitors are important cancer therapeutics. Polypharmacology is commonly observed, requiring thorough target deconvolution to understand drug... 
REFINEMENT | PROTEIN | CHEMICAL PROTEOMICS | INHIBITOR SELECTIVITY | DATA QUALITY | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | INTEGRATIVE GENOMICS VIEWER | SALT-INDUCIBLE KINASES | CANCER | COMPREHENSIVE ANALYSIS | fms-Like Tyrosine Kinase 3 - antagonists & inhibitors | Lung Neoplasms - drug therapy | Lung Neoplasms - enzymology | Cytokines - metabolism | Humans | Drug Discovery - methods | Antineoplastic Agents - chemistry | Molecular Targeted Therapy | Xenograft Model Antitumor Assays | Leukemia, Myeloid, Acute - enzymology | Protein Kinase Inhibitors - chemistry | Animals | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Line, Tumor | Leukemia, Myeloid, Acute - drug therapy | Antineoplastic Agents - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Proteomics - methods | Salts | Target recognition | Lung cancer | Selectivity | Drug development | Cancer therapies | Signal transduction | Biomolecules | Protein-tyrosine kinase | Tyrosine | Medical research | Imatinib | Decision making | Medical treatment | Mass spectroscopy | Tumor necrosis factor-α | Embryos | Bruton's tyrosine kinase | Mode of action | Side effects | Inhibitors | Interleukin 10 | Affinity | Drug discovery | Mass spectrometry | Acute myeloid leukemia | Drugs | Deregulation | Leukemia | Interleukin | Medical services | Clinical trials | Leucine | Kinases | Biological effects | Epidermal growth factor | Salt-inducible kinase | Xenografts | Cell survival | Epidermal growth factor receptors | Research & development--R&D | Therapeutic applications | Myeloid leukemia | Markers | Data processing | Lead compounds | Leucine zipper proteins | Signaling | Proteomics | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 10, pp. 1364 - 1372
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 12, pp. 1350 - 1357
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2016, Volume 95, Issue 12, pp. 1931 - 1942
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2014, Volume 124, Issue 12, pp. 5263 - 5274
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2016, Volume 22, Issue 7, pp. 735 - 743
Immunomodulatory drugs (IMiDs), such as thalidomide and its derivatives lenalidomide and pomalidomide, are key treatment modalities for hematologic... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | THALIDOMIDE | CEREBLON | MULTIPLE-MYELOMA CELLS | CANCER-THERAPY | CELL BIOLOGY | 5Q DELETION | LENALIDOMIDE | DEXAMETHASONE COMBINATION | MYELODYSPLASTIC SYNDROMES | T-CELLS | E3 UBIQUITIN LIGASE | Cell Cycle Proteins - drug effects | Oncogene Proteins - genetics | Peptide Hydrolases - genetics | Humans | Peptide Hydrolases - drug effects | Thalidomide - pharmacology | RNA, Messenger - metabolism | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Basigin - genetics | Basigin - drug effects | Cell Cycle Proteins - genetics | Immunosuppressive Agents - pharmacology | Myelodysplastic Syndromes - drug therapy | Peptide Hydrolases - metabolism | RNA, Messenger - drug effects | Myelodysplastic Syndromes - metabolism | Teratogenesis - genetics | Cell Cycle Proteins - metabolism | Oncogene Proteins - metabolism | Multiple Myeloma - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Oncogene Proteins - drug effects | Signal Transduction - drug effects | Basigin - metabolism | Myelodysplastic Syndromes - genetics | Immunologic Factors - pharmacology | Multiple Myeloma - genetics | Teratogenesis - drug effects | Cellular proteins | Immunity | Carcinogenesis | Health aspects | Patient outcomes | Risk factors | Proteins | Drug therapy | Multiple myeloma | Tumors | Index Medicus
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 2017, Volume 214, Issue 1, pp. 165 - 181
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. 1668 - 1679
Journal Article
Transfusion, ISSN 0041-1132, 07/2018, Volume 58, Issue 7, pp. 1772 - 1780
BACKGROUNDCell separators are routinely used to collect CD34(+) blood stem cells in the context of customized stem cell transplantation procedures. The Spectra... 
SYSTEM | PROGENITOR | SEPARATOR | BONE-MARROW | DONORS | HEMATOLOGY | EFFICIENCY | BLOOD | Transplantation | Magneto-electric machines | Machinery | Analysis | Hematopoietic stem cells | Stem cells | CD34 antigen | Autografts | Apheresis | Body weight | Hematocrit | Spectra | Separators | Donors | Collection | Platelets | Viability | Index Medicus
Journal Article